Truist Securities Reiterates Gilead Sciences (GILD) at Hold, Stock Presents Attractive Opportunity for Long-term Investors
Tweet Send to a Friend
Truist Securities analyst Robyn Karnauskas reiterated a Hold rating and $75.00 price target on Gilead Sciences (NASDAQ: GILD), following recently ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
